OPKO Completes Sale of Sorrento Therapeutics Stake
December 19, 2013 at 10:22 AM EST
OPKO Health, Inc. (NYSE: OPK ) has completed the sale of its stake in Sorrento Therapeutics, Inc. (NASDAQ: SRNE ), a publicly-traded, clinical-stage biopharmaceutical company focused primarily
